Renocrit 4000IU Injection

Product Description

Renocrit 4000IU Injection contains Recombinant human erythropoietin alpha, is used to treat anemia from HIV treatment, cancer chemotherapy, and renal illness by stimulating the bone marrow to create more red blood cells.

Usually provided by a doctor or nurse, the injection might be given beneath the skin or into a vein, depending on your doctor's decision. Body weight and the underlying cause of anemia determine the dosage. Supplementing with iron may increase the treatment's efficacy. Although it should be used at room temperature, Renocrit should be kept in a refrigerator.

Brand Name: Renocrit

Composition: Recombinant Human Erythropoietin Alpha

Mechanism of Action:

The activity of natural erythropoietin is mimicked by recombinant human erythropoietin alpha. By attaching itself to bone marrow erythropoietin receptors, it promotes erythropoiesis, the process by which red blood cells are produced, and it speeds up the development of erythroid progenitor cells. Hemoglobin levels rise as a result, and symptoms associated with anemia improve.

Uses:

• Chronic Kidney Disease-Related Anemia
• Anemia in Cancer Patients
• HIV Patients with Anemia

Side effects:

Hypertension (high blood pressure)

Fatigue

Nausea

Vomiting

Dizziness

Diarrhea

Anorexia

Weight loss

Liver dysfunction

Dosage and Administration:

Renocrit can be injected intravenously or subcutaneously. The patient's health, reaction to treatment, and desired hemoglobin levels all influence the dosage and timing. Although particular regimens may vary, it is typically administered one to three times each week.